[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO961475L - Indol-derivater - Google Patents

Indol-derivater

Info

Publication number
NO961475L
NO961475L NO961475A NO961475A NO961475L NO 961475 L NO961475 L NO 961475L NO 961475 A NO961475 A NO 961475A NO 961475 A NO961475 A NO 961475A NO 961475 L NO961475 L NO 961475L
Authority
NO
Norway
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Application number
NO961475A
Other languages
English (en)
Other versions
NO309861B1 (no
NO961475D0 (no
Inventor
Alfredo Cugola
Romano Di Fabio
Giorgio Pentassuglia
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of NO961475L publication Critical patent/NO961475L/no
Publication of NO961475D0 publication Critical patent/NO961475D0/no
Publication of NO309861B1 publication Critical patent/NO309861B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO961475A 1993-10-14 1996-04-12 Indol-derivater, anvendelse derav og farmasøytisk preparat NO309861B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321221A GB9321221D0 (en) 1993-10-14 1993-10-14 Heterocyclic compounds
PCT/EP1994/003359 WO1995010517A1 (en) 1993-10-14 1994-10-12 Indole derivatives as nmda antagonists

Publications (3)

Publication Number Publication Date
NO961475L true NO961475L (no) 1996-04-12
NO961475D0 NO961475D0 (no) 1996-04-12
NO309861B1 NO309861B1 (no) 2001-04-09

Family

ID=10743550

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961475A NO309861B1 (no) 1993-10-14 1996-04-12 Indol-derivater, anvendelse derav og farmasøytisk preparat

Country Status (27)

Country Link
US (3) US5760059A (no)
EP (1) EP0723541A1 (no)
JP (1) JPH09503770A (no)
CN (1) CN1070490C (no)
AP (1) AP574A (no)
AU (1) AU681194B2 (no)
BG (1) BG61839B1 (no)
CA (1) CA2171449A1 (no)
CO (1) CO4290355A1 (no)
CZ (1) CZ92396A3 (no)
FI (1) FI961628A0 (no)
GB (1) GB9321221D0 (no)
HU (1) HU219710B (no)
IL (1) IL111294A (no)
IS (1) IS4219A (no)
MY (1) MY112411A (no)
NO (1) NO309861B1 (no)
NZ (1) NZ274179A (no)
OA (1) OA10578A (no)
PE (1) PE21995A1 (no)
PL (1) PL179568B1 (no)
RU (1) RU2144535C1 (no)
SG (1) SG49013A1 (no)
SK (1) SK44996A3 (no)
TW (1) TW283144B (no)
WO (1) WO1995010517A1 (no)
ZA (1) ZA947948B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9704499D0 (en) 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
JP2002540098A (ja) 1999-03-23 2002-11-26 住友製薬株式会社 三環性インドール−2−カルボン酸化合物
DE10153346A1 (de) 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
RU2361862C2 (ru) 2003-12-29 2009-07-20 Сепракор Инк. Пиррольные и пиразольные ингибиторы daao
WO2007006003A2 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
NZ569608A (en) * 2006-01-06 2011-09-30 Sepracor Inc Tetralone-based monoamine reuptake inhibitors
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
ES2555315T3 (es) 2006-03-31 2015-12-30 Sunovion Pharmaceuticals Inc. Preparación de amidas y aminas quirales
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
CN101636384A (zh) * 2007-01-18 2010-01-27 塞普拉柯公司 D-氨基酸氧化酶的抑制剂
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
KR101581289B1 (ko) 2007-05-31 2015-12-31 세프라코 아이엔시. 모노아민 재흡수 억제제로서 페닐 치환된 시클로알킬아민
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
CA2755118A1 (en) * 2009-03-10 2010-09-16 Santen Pharmaceutical Co., Ltd. Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
EP3718547A1 (en) 2011-10-03 2020-10-07 The University of Utah Research Foundation Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
DK3137658T3 (da) 2014-04-30 2022-05-02 Yufeng Jane Tseng Anvendelse af kendte forbindelser som d-aminosyreoxidase-inhibitorer
ES2974883T3 (es) 2016-09-14 2024-07-02 Yufeng Jane Tseng Nuevos derivados de benzimidazol sustituidos utilizados como inhibidores de la D-aminoácido oxidasa (DAAO)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
CA2083891A1 (en) * 1991-12-03 1993-06-04 Angus Murray Macleod Heterocyclic compounds, compositions containing them and their use in therapy
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
EP0587377A3 (en) * 1992-09-10 1994-09-21 Lilly Co Eli Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
FI961628A (fi) 1996-04-12
IL111294A0 (en) 1994-12-29
EP0723541A1 (en) 1996-07-31
IS4219A (is) 1995-04-15
HU219710B (hu) 2001-06-28
HUT76065A (en) 1997-06-30
US5962496A (en) 1999-10-05
JPH09503770A (ja) 1997-04-15
HU9600969D0 (en) 1996-06-28
AP574A (en) 1997-01-30
BG61839B1 (bg) 1998-07-31
NZ274179A (en) 1998-01-26
TW283144B (no) 1996-08-11
IL111294A (en) 1998-12-06
AU681194B2 (en) 1997-08-21
SK44996A3 (en) 1997-01-08
US5760059A (en) 1998-06-02
PE21995A1 (es) 1995-08-14
GB9321221D0 (en) 1993-12-01
OA10578A (en) 2002-06-07
NO309861B1 (no) 2001-04-09
US6100289A (en) 2000-08-08
AU7813394A (en) 1995-05-04
ZA947948B (en) 1995-05-23
CO4290355A1 (es) 1996-04-17
PL313969A1 (en) 1996-08-05
NO961475D0 (no) 1996-04-12
SG49013A1 (en) 1998-05-18
FI961628A0 (fi) 1996-04-12
AP9400685A0 (en) 1994-10-31
RU2144535C1 (ru) 2000-01-20
BG100511A (en) 1996-11-29
CA2171449A1 (en) 1995-04-20
PL179568B1 (pl) 2000-09-29
MY112411A (en) 2001-06-30
CN1133042A (zh) 1996-10-09
WO1995010517A1 (en) 1995-04-20
CZ92396A3 (en) 1996-08-14
CN1070490C (zh) 2001-09-05

Similar Documents

Publication Publication Date Title
FI944969A (fi) Indolijohdannaisia
NO943913L (no) Indol-derivater
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
NO961475L (no) Indol-derivater
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DE69330497D1 (de) Chinazolin-derivate
DE69212058D1 (de) Indol-Derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
NO954323D0 (no) Heterocykliske derivater
ATA100695A (de) Prothrombin-derivate
FI940311A (fi) Indoleja
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
DE69527786D1 (de) Diaminomethyliden-derivate
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
ATE177102T1 (de) Chromanderivate
DK0725061T3 (da) Substituerede indolderivater
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69624122D1 (de) Aza-anthracyclinone-derivate
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
DE69510792D1 (de) Naphtochinonderivate
DE69620514D1 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2002